Edition:
United Kingdom

People: BioTelemetry Inc (BEAT.OQ)

BEAT.OQ on NASDAQ Stock Exchange Global Select Market

47.43USD
17 Jul 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$47.43
Open
$47.68
Day's High
$48.00
Day's Low
$47.35
Volume
126,880
Avg. Vol
171,029
52-wk High
$80.80
52-wk Low
$46.19

Broadway, Fred 

Mr. Fred (Andy) Broadway III serves as President, BioTel Heart of the BioTelemetry Inc. Mr. Broadway was named President of BioTel Heart in January 2018. In this role, Mr. Broadway has leadership for all sales, marketing, customer service, monitoring, contracting, reimbursement and distribution teams supporting the Healthcare Services business. Mr. Broadway joined us in June 2009 as our Vice President, Marketing, bringing 15 years of progressive leadership experience in sales and marketing, including extensive therapeutic knowledge in Cardiology and Neurology. In September 2012, Mr. Broadway was promoted to Senior Vice President, Marketing, and in January 2013, Mr. Broadway became our Senior Vice President, Sales and Marketing. Prior to joining us, from 2006 to June 2009, Mr. Broadway was Director of Marketing at Bristol Myers Squibb, leading the commercialization launch efforts of a potential new therapy for the treatment of stroke prevention in atrial fibrillation. Earlier in his career, Mr. Broadway was on the marketing team at Pfizer, responsible for developing yearly and long-term strategic plans, brand and portfolio positioning, asset life cycle development, and overseeing commercialization tactics for several leading brands. Mr. Broadway started his career with Sanofi Pharmaceuticals, where he held numerous positions of increasing responsibility including sales, marketing, and eventually leadership positions in both sales and marketing. Mr. Broadway received his undergraduate degree in Zoology from Auburn University.

Basic Compensation

Total Annual Compensation, USD 344,636
Restricted Stock Award, USD 258,594
Long-Term Incentive Plans, USD --
All Other, USD 404,184
Fiscal Year Total, USD 1,007,410

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 9,179 314,381.00
Name Fiscal Year Total

Kirk Gorman

230,658

Joseph Capper

3,875,560

Heather Getz

1,632,580

Fred Broadway

1,007,410

Peter Ferola

917,995

Daniel Wisniewski

935,098
As Of  31 Dec 2018